Alcester, Warwickshire, UK, 12 August 2019: Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a pioneering British medical technology company developing a personal haemodialysis system (SC+) for patient use at home and in the clinic, announces that it has selected Benchmark Electronics Inc. (“Benchmark”) (BHE), a global provider of manufacturing, engineering and design services, as its production partner for the SC+ haemodialysis machine.
Benchmark has over 40 years of experience working with medical device companies. With specific expertise in complex medical systems, fluidics and electronics assembly, Benchmark is the ideal partner for Quanta. Importantly, Benchmark’s world-class capabilities in the mass-production of FDA and ISO13485 certified medical devices position Quanta to meet the growing demand for home dialysis solutions such as SC+.
A first batch of prototype SC+ haemodialysis machines was manufactured at Benchmark earlier this year, with final production units expected to follow as Quanta ramps up for commercial launch in the UK in Q4 2019.
John E. Milad, Chief Executive Officer of Quanta said: “With the planned commercial launch of our updated SC+ personal haemodialysis system later this year, it was imperative for us to secure the right manufacturing partner for Quanta – one that shares our passion for excellence and our transformational vision. We are pleased to have partnered with Benchmark—a recognised global leader in the manufacturing and servicing of complex medical devices.”
Todd Martensen, Vice President, Medical Sector of Benchmark said: “Quanta has demonstrated innovation in medical device technology and we are delighted to support them as their strategic manufacturing partner as they bring their products to mass market. Benchmark’s 40-year heritage in medical technologies and our dedicated global medical design and manufacturing team allows us to address our customers’ most advanced challenges.”